AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Sitalong M 50mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Alteus Biogenics Pvt Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitalong M 50mg/500mg Tablet

Duo-Med 50mg/500mg tablets combine two medications to manage elevated blood glucose in type 2 diabetes patients. This dual action helps prevent serious diabetic complications like renal impairment and vision loss, potentially lowering heart attack and stroke risk. Duo-Med 50mg/500mg may be prescribed alone or with other antidiabetic agents. Optimal results require adherence to a balanced diet and regular physical activity. Dosage is individualized, considering your health status, glucose levels, and concurrent medications. Taking it with food minimizes gastrointestinal discomfort. Consistent daily dosing, at the same time, maximizes effectiveness; discontinuation should only occur under physician guidance. Continued adherence to your prescribed diet and exercise plan is crucial for diabetes control; lifestyle modifications significantly impact disease management. Common side effects include diarrhea, nausea, vomiting, indigestion, headache, and pharyngitis. Low blood sugar (hypoglycemia) is a potential side effect when used with insulin or sulfonylureas; learn its symptoms and management. This medication isn't suitable for all individuals. Inform your physician of any pre-existing kidney, liver, or heart conditions, pancreatic issues, or excessive alcohol consumption before starting treatment. Pregnant or lactating women should seek medical advice prior to use. Potential interactions exist with other medications; disclose all medications to ensure safety. Alcohol consumption should be minimized due to its hypoglycemic effect. Your doctor will monitor kidney function and blood glucose levels throughout your treatment.

Primary Ingredients of Sitalong M 50mg/500mg Tablet

No text provided. Please provide the text you wish me to rephrase.

Uses of Sitalong M 50mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Sitalong M 50mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Sitalong M 50mg/500mg Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

Common Side effects of Sitalong M 50mg/500mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitalong M 50mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Sitalong M 50mg/500mg Tablet whole; do not crush, chew, or fracture it. Administer this medication with food.

How Sitalong M 50mg/500mg Tablet works:

Sitalong M, a 50mg/500mg tablet, combines sitagliptin and metformin to manage blood glucose. Sitagliptin boosts insulin production by the pancreas, improves insulin utilization, and reduces hepatic glucose output. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity. This dual action results in superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Sitalong M 50mg/500mg Tablet with alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitalong M 50mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against possible hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Breastfeeding while taking Sitalong M 50mg/500mg tablets is likely inadvisable. Available data from human studies indicate potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitalong M 50mg/500mg tablets cautiously, potentially requiring dosage modification. Consult your physician for guidance. Sitalong M 50mg/500mg tablets are contraindicated in patients with severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

Patients with liver conditions should likely avoid Sitalong M 50mg/500mg tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Sitalong M 50mg/500mg Tablet :

Should you forget a Sitalong M 50mg/500mg Tablet dose, administer it immediately upon recollection. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitalong M 50mg/500mg Tablet

LabelValue
Potential for Dependence None.
Medication Classification Medication for diabetes

FAQs on Sitalong M 50mg/500mg Tablet

Sitalong M 50mg/500mg tablets contain sitagliptin and metformin, working together to manage type 2 diabetes in adults. This medication improves blood sugar control when combined with a healthy diet and regular physical activity. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin blocks DPP4, boosting pancreatic insulin release. This formulation is unsuitable for individuals under 18.
Prolonged Sitalong M 50mg/500mg Tablet use can indeed lead to vitamin B12 deficiency. This medication hinders the stomach's absorption of vitamin B12. Consequently, untreated deficiency may manifest as anemia and neurological issues, including tingling and numbness in extremities, muscle weakness, urinary dysfunction, cognitive changes, and impaired balance. To mitigate these risks, supplemental vitamin B12 intake, at a minimum annually, has been proposed by some studies.
Sitalong M 50mg/500mg Tablet may cause common side effects including low blood sugar (hypoglycemia), taste disturbances, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Patients with hypersensitivity to any Sitalong M 50mg/500mg Tablet constituent should not use this medication. Similarly, its use is contraindicated in individuals with severe renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitalong M 50mg/500mg Tablet and alcohol is unsafe due to a heightened risk of lactic acidosis.
Retain this medication within its original, sealed container or packaging. Follow the storage guidelines provided on the packaging or label. Discard any leftover medication. Prevent access by children, pets, and others.
Sitagliptin/metformin combination tablets (e.g., 50mg/500mg) can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare adverse reaction necessitates caution in individuals with kidney impairment, the elderly, or those consuming substantial alcohol. Symptoms may encompass muscle aches or weakness, vertigo, fatigue, cold extremities, dyspnea, nausea, emesis, abdominal discomfort, or bradycardia. Should these symptoms appear, discontinue Sitagliptin/metformin immediately and seek medical attention.
The tablet Sitalong M, containing 50mg Sitagliptin and 500mg Metformin, treats type 2 diabetes mellitus in adults. This dual-drug therapy enhances blood sugar control when combined with a healthy diet and exercise regimen. Metformin reduces hepatic glucose production and improves insulin responsiveness. Sitagliptin's mechanism involves DPP4 enzyme inhibition, stimulating pancreatic insulin secretion. This medication is unsuitable for individuals under 18.
Sitalong M 50mg/500mg tablets may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but potentially serious side effects such as lactic acidosis can occur. Prolonged use might result in vitamin B12 deficiency.
Patients with hypersensitivity to Sitalong M 50mg/500mg Tablet constituents or inactive ingredients should not use this medication. Its use is contraindicated in individuals experiencing severe renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitalong M 50mg/500mg Tablet with alcohol is unsafe and may raise the risk of lactic acidosis.
Lactic acidosis, a serious medical condition resulting from excessive blood lactic acid, is a potential side effect of Sitalong M 50mg/500mg Tablet. Also termed Metformin-associated lactic acidosis (MALA), this rare complication necessitates caution in patients with impaired kidney function, advanced age, or significant alcohol consumption. Symptoms such as muscle aches, weakness, vertigo, fatigue, cold extremities, dyspnea, nausea, emesis, abdominal discomfort, or bradycardia warrant immediate discontinuation of Sitagliptin + Metformin and prompt medical attention.
Prolonged use of Sitalong M 50mg/500mg Tablets can indeed lead to vitamin B12 deficiency. This is due to the medication's interference with the stomach's absorption of vitamin B12. Untreated deficiency can manifest as anemia and neurological complications, including tingling, numbness in the extremities, muscle weakness, urinary issues, cognitive changes, and impaired balance. To mitigate these risks, supplemental vitamin B12 intake, at a minimum of once annually, has been recommended by some studies.
Retain this medication in its original, sealed container. Follow the storage guidelines printed on the packaging. Discard any leftover medication. Prevent access by children, pets, and others.
Sitalong M 50mg/500mg tablets contain sitagliptin and metformin, working synergistically to manage type 2 diabetes in adults. This medication aids in blood sugar control when combined with a healthy diet and regular physical activity. Metformin reduces hepatic glucose production and enhances insulin sensitivity, while sitagliptin's DPP-4 inhibition promotes increased pancreatic insulin secretion. This formulation is unsuitable for individuals under 18.
Sitalong M 50mg/500mg Tablets may cause common side effects including low blood sugar (hypoglycemia), taste disturbances, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but serious adverse reactions such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Patients with hypersensitivity to any Sitalong M 50mg/500mg Tablet constituent or inactive ingredient should not use this medication. Similarly, its use is contraindicated in individuals with severely compromised kidney or liver function, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Consuming alcohol concurrently with Sitalong M 50mg/500mg tablets is unsafe due to a heightened risk of lactic acidosis.
Metformin-containing medications, such as Sitalong M 50mg/500mg Tablet, carry a risk of lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-Associated Lactic Acidosis (MALA), this rare adverse effect necessitates caution in individuals with pre-existing kidney impairment, advanced age, or significant alcohol consumption. Symptoms can manifest as muscle aches or weakness, lightheadedness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal discomfort, or bradycardia. Should these symptoms arise, discontinue Sitagliptin + Metformin immediately and seek urgent medical attention.
Prolonged use of Sitalong M 50mg/500mg Tablets can indeed lead to Vitamin B12 deficiency. This medication impedes the stomach's absorption of Vitamin B12. Consequently, untreated deficiency may manifest as anemia and neurological issues, including tingling and numbness in the extremities, muscle weakness, bladder dysfunction, cognitive changes, and impaired coordination. Preventive measures, as proposed by some studies, include annual supplemental Vitamin B12 intake.
Store this medication in its original, tightly sealed container or packaging, following all storage instructions provided on the label. Discard any remaining medication. Ensure it remains inaccessible to children, pets, and other individuals.
Sitalong M 50mg/500mg Tab...
181
MRP 210
13% off